CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

NCT06258447 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Heart Failure

Interventions

DEVICE: Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system

Sponsor

BioCardia, Inc.